Definitive CCRT Combined With Durvalumab and Tremelimumab for Inoperable Esophageal Cancer
Clinical trial NCT03377400 · UNKNOWN
Trial details
- NCT number
- NCT03377400
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-14
- Primary completion
- 2021-06-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.